Singapore markets closed

Corvus Pharmaceuticals, Inc. (CRVS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.5100+0.0300 (+1.99%)
As of 01:31PM EDT. Market open.
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
12,620
13,159
63,458
16,455
Other short-term investments
14,529
29,144
5,993
27,804
Total cash
27,149
42,303
69,451
44,259
Net receivables
26
588
507
0
Other current assets
220
102
128
406
Total current assets
27,956
43,664
71,312
45,336
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
6,082
7,116
7,893
6,346
Accumulated depreciation
-4,697
-4,546
-4,252
-3,792
Net property, plant and equipment
1,385
2,570
3,641
2,554
Equity and other investments
16,123
21,877
34,266
37,225
Other long-term assets
89
129
236
414
Total non-current assets
17,597
24,576
38,143
40,193
Total assets
45,553
68,240
109,455
85,529
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
1,525
1,976
1,565
3,467
Accrued liabilities
3,041
6,277
5,114
5,199
Other current liabilities
245
158
121
180
Total current liabilities
6,869
10,752
9,692
12,149
Non-current liabilities
Total non-current liabilities
0
1,373
2,601
1,232
Total liabilities
6,869
12,125
12,293
13,381
Stockholders' equity
Common stock
5
5
5
3
Retained earnings
-334,717
-307,688
-266,381
-223,140
Accumulated other comprehensive income
-967
-563
1,869
4
Total stockholders' equity
38,684
56,115
97,162
72,148
Total liabilities and stockholders' equity
45,553
68,240
109,455
85,529